Guus A M S van Dongen

3PUBLICATIONS
14CO-AUTHORS
Tissue engineeringPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 18, 2024
Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

Joey A Muns, Erik Schooten, Rychon D J van Dasselaar

|Feb 15, 2022
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.

Valentina Boni, Mary J Fidler, Hendrik-Tobias Arkenau

|Aug 03, 2021
Improving Tumor Penetration of Antibodies and Antibody-Drug Conjugates: Taking Away the Barriers for Trojan Horses.

Guus A M S van Dongen

Pageof 1

Frequent Collaborators

1 joint publications

Valentina Boni

1 joint publications

Funda Meric-Bernstam

1 joint publications

Rachel E Sanborn

1 joint publications

Randy F Sweis